The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small-cell lung cancer (NSCLC) cases comprise approximately 85% of the lung cancer cases. Before the era of target therapy, platinum-based doublet chemotherapy only led to a median survival of 8–9 months and a one-year survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Shih-Chieh, Chang, Cheng-Yu, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757436/
https://www.ncbi.nlm.nih.gov/pubmed/24212826
http://dx.doi.org/10.3390/cancers3022667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757436/
https://www.ncbi.nlm.nih.gov/pubmed/24212826
http://dx.doi.org/10.3390/cancers3022667

Ejemplares similares